2020 AHA/ACC肥厚型心肌病诊断与治疗指南执行摘要
该执行摘要基于2010年至2020年的综合文献检索,为成人和儿童肥厚型心肌病患者提供诊断与管理建议及流程图。指南更新了既往推荐,涵盖诊断检查、遗传与家族筛查、风险分层、生活方式调整、手术与导管干预及药物治疗。
要点
- 指南为成人和儿童肥厚型心肌病患者提供诊断与管理建议及流程图。
- 更新了既往推荐,纳入新证据或对早期证据的更好理解。
- 内容涵盖诊断检查、遗传与家族筛查、风险分层、生活方式、手术与导管干预及药物。
核心结论
- 该执行摘要操作化了完整指南的推荐,整合诊断检查、遗传与家族筛查、风险分层、生活方式调整、手术与导管干预及药物治疗。
研究设计与样本
- 综合文献检索于2010年1月1日至2020年4月30日进行,涵盖PubMed、EMBASE、Cochrane Collaboration、AHRQ报告等数据库发表的英文人类研究、综述及其他证据。
主要发现
- 既往肥厚型心肌病指南的许多推荐已根据新证据或对早期证据的更好理解进行了更新。
临床怎么用
- 指南导向药物治疗及其他推荐药物治疗方案,读者应依据产品说明书遵循剂量、禁忌症和药物相互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. Methods A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Structure Many recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.
引用
- Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020. PMID: 33215938. doi:10.1161/CIR.0000000000000938
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。